“…For instance, in vivo production of antiviral agents including human interferon-γ against influenza virus H1N1 in T. ni larvae have been demonstrated Gomez-Casado et al, 2011). Nevertheless, insect cell cultures and BEVs platforms continue to expand the applications of baculoviruses as novel tools for vaccine development, drug screening, and gene therapy (Airenne et al, 2010(Airenne et al, , 2011Cox & Hollister, 2009, Kost et al, 2005, van Oers, 2011. The recent initiative of having a standard baculovirus reference material repository (BRM) will further boost their application and perhaps hasten the regulatory process for registering new baculovirus products (Kamen et al, 2011).…”